Back to Search
Start Over
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data.
- Source :
-
Leukemia & Lymphoma . Jan2018, Vol. 59 Issue 1, p256-258. 3p. - Publication Year :
- 2018
- Subjects :
- *TRANSLATION initiation factors (Biochemistry)
*RIBAVIRIN
*LYMPHOMA treatment
Subjects
Details
- Language :
- English
- ISSN :
- 10428194
- Volume :
- 59
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Leukemia & Lymphoma
- Publication Type :
- Academic Journal
- Accession number :
- 125435365
- Full Text :
- https://doi.org/10.1080/10428194.2017.1323270